Johnson & Johnson on Wednesday said it has won Food and Drug Administration fast-track designation for its proposed posdinemab treatment for Alzheimer's disease. J&J is investigating the internally ...
A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...